Bezafibrate Prescribing at ROTHSCHILD HOUSE GROUP
Lipid-regulating drugs | Cardiovascular System
Items (12m)
286
Total Quantity
9,414
NHS Cost
£1.8K
vs National Avg
+431%
ROTHSCHILD HOUSE GROUP prescribed 286 items of Bezafibrate over the last 12 months at a cost of £1,838 to the NHS. This is 431% above the national average prescribing rate. Bezafibrate is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jun 2026
22
Jun 2026
22
Jun 2026
29
Jun 2026
24
Jun 2026
28
Jun 2026
25
Jun 2026
25
Jun 2026
24
Jun 2026
25
Jun 2026
22
Jun 2026
17
Jun 2026
23
Prescribing Details
| Total Items | 286 |
|---|---|
| Total Quantity | 9,414 |
| Total NHS Cost | £1,838 |
| Presentations | 3 different forms |
| vs National Average | +431% |
Bezafibrate Prescribing Comparison
| This practice | 286 items |
|---|---|
| National average per practice | 54 items |
| Difference | +431% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.